Shankar Viswanathan to Lung Neoplasms
This is a "connection" page, showing publications Shankar Viswanathan has written about Lung Neoplasms.
Connection Strength
0.260
-
Ohri N, Jolly S, Cooper BT, Kabarriti R, Bodner WR, Klein J, Guha C, Viswanathan S, Shum E, Sabari JK, Cheng H, Gucalp RA, Castellucci E, Qin A, Gadgeel SM, Halmos B. Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT). J Clin Oncol. 2024 Feb 10; 42(5):562-570.
Score: 0.133
-
Sheni R, Qin J, Viswanathan S, Castellucci E, Kalnicki S, Mehta V. Predictive Factors for Cancer Treatment Delay in a Racially Diverse and Socioeconomically Disadvantaged Urban Population. JCO Oncol Pract. 2023 06; 19(6):e904-e915.
Score: 0.127